Interferon-Free Combination Therapy Is Effective for Hepatitis C Patients | Hepatitis Central

The latest research & treatment news about Hepatitis C infection, diagnosis, symptoms and treatment.

Menu Search
Previous

Medivir Discontinues NS5A Inhibitor Program

Back to News Homepage
Next

How Does Turmeric Impact Hepatitis?

Interferon-Free Combination Therapy Is Effective for Hepatitis C Patients

The Editors at Hepatitis Central
August 20, 2013

Print this page

Learn about a new interferon-free regimen that achieved sustained virologic response rates close to 70% in a phase II clinical trial.

Interferon-free regimens effective for hepatitis C virus genotype 1

By: MARY ANN MOON, Family Practice News Digital Network

An interferon-free regimen of faldaprevir, deleobuvir, and ribavirin proved to be effective in a phase II clinical trial involving 362 patients with previously untreated chronic hepatitis C virus genotype 1 infection, according to a report published in the New England Journal of Medicine.

The new combination therapy achieved sustained virologic response rates of 52%-69% 12 weeks after treatment was completed, reported Dr. Stefan Zeuzem of Johann Wolfgang Goethe University Medical Center, Frankfurt am Main (Germany), and his associates (N. Engl. J. Med. 2013;369:630-9).

Continue reading this entire article:
http://www.familypracticenews.com/news/infectious-diseases/single-article/interferon-free-regimens-effective-for-hepatitis-c-virus-genotype-1/f0d12bbc40cadeffc901cecae8255675.html

41 Comments
Share
Share
Previous

Medivir Discontinues NS5A Inhibitor Program

Back to News Homepage
Next

How Does Turmeric Impact Hepatitis?

Requirements for using and reposting articles

Comments

HepatitisCentral.com provides information regarding hepatitis and liver disease. Comments are available to the community in order to discuss these topics and obtain answers to questions through community members. The Editors at HepatitisCentral.com will not be responding to questions or comments posed in article comments.